Bullock Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.53M Sell
2,962
-145
-5% -$148K 1.53% 10
2026
Q1
$2.97M Sell
3,107
-103
-3% -$104K 1.49% 9
2025
Q4
$3.45M Sell
3,210
-38
-1% -$36.3K 1.69% 9
2025
Q3
$2.68M Buy
3,248
+252
+8% +$188K 1.33% 11
2025
Q2
$2.32M Sell
2,996
-8
-0.3% -$6.22K 1.23% 12
2025
Q1
$2.42M Buy
3,004
+154
+5% +$128K 1.35% 10
2024
Q4
$2.2M Buy
2,850
+109
+4% +$90.3K 1.28% 12
2024
Q3
$2.42M Buy
2,741
+333
+14% +$299K 1.46% 9
2024
Q2
$2.2M Buy
2,408
+51
+2% +$40.8K 1.44% 10
2024
Q1
$1.79M Buy
+2,357
New +$1.68M 1.2% 13

Other funds holding LLY

Bullock Wealth Management's LLY Position: Q2 2026 in Review

Bullock Wealth Management reduced its Eli Lilly (LLY) stake by 4.7% in Q2 2026, selling an estimated $148K and leaving 2,962 shares worth $3.53M. The position accounts for 1.53% of the portfolio, ranked #10.

Bullock Wealth Management first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Bullock Wealth Management held 2,962 shares of Eli Lilly worth $3.53M as of Q2 2026.
  • Bullock Wealth Management sold 145 Eli Lilly shares in Q2 2026, an estimated $148K.
  • Eli Lilly made up 1.53% of Bullock Wealth Management's portfolio in Q2 2026, its #10 holding.
  • Bullock Wealth Management first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Bullock Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.